Reports of Patent, Design, and Trade Mark Cases, Issues 1-5; Issues 8-13Published at the Patent Office Sales Branch, 2003 - Industrial property |
From inside the book
Results 1-3 of 87
Page 57
... claim 1 sequence and excludes those that are not the product of such a process . Such a claim is consistent with Art.64 ( 2 ) of the EPC which allows patents to " extend to the products directly obtained by such process " . If patents ...
... claim 1 sequence and excludes those that are not the product of such a process . Such a claim is consistent with Art.64 ( 2 ) of the EPC which allows patents to " extend to the products directly obtained by such process " . If patents ...
Page 64
... claim 19 as we have already concluded that the TKT product does not fall within the literal meaning of claim 19. However , the judge's conclusion as to the meaning of recombinant would appear to be correct . Further , resort to the ...
... claim 19 as we have already concluded that the TKT product does not fall within the literal meaning of claim 19. However , the judge's conclusion as to the meaning of recombinant would appear to be correct . Further , resort to the ...
Page 77
... claim 20 is insufficient on that ground . In any event , it is insufficient for the reasons given in relation to claim 19 , given that it incorporates that claim by reference . ” It seems that the judge held claim 20 insufficient ...
... claim 20 is insufficient on that ground . In any event , it is insufficient for the reasons given in relation to claim 19 , given that it incorporates that claim by reference . ” It seems that the judge held claim 20 insufficient ...
Other editions - View all
Common terms and phrases
ALBERTA FERRETTI amendment Amgen amino acid Appointed Person Arsenal FC Arsenal Football Club burner cell claim 19 claimant colour common general knowledge contact lens CooperVision Court of Appeal cross-examination Davies decision defendants Directive distinctive character DNA sequence dots earlier trade mark effect erythropoietin European Patent evidence filed gene hearing officer High Court Inc v Transkaryotic infringement Integer inventive step iris section issue judge judgment Kirin-Amgen Inc lenses likelihood of confusion Ltd's Trade Mark Marks Act 1994 Meneghetti non-use opponent paragraph numbers paras Patent Office Philips Electronics NV Plc v Reed prior art priority date protein question Quickfit reason Reed Business Information referred registered trade mark registrar relation relevant Remington Consumer Products revocation shape Silverleaf specification submissions Sweet & Maxwell Synthon third party TORRES TRADE MARK 2003 Trade Mark Application trade mark proprietor Trade Marks Act Transkaryotic Therapies Inc uEPO United Kingdom word